United States Pharmaceuticals & Healthcare Q1 2019
The outcome of the November 2018 midterm elections reduces the prospect of new legislation targeting high drugprices. This is a moderately positive outcome for pharmaceutical companies, which have been under pressure from PresidentTrump to lower costs for patients. Nevertheless, due to widespread concern among politicians and the public, high drug prices willbe the major issue in the US pharmaceutical market in 2019.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook